Supernus schedules Q4 and full year 2024 earnings release and call for Feb 25, 2025

SUPERNUS PHARMACEUTICALS, INC.

Earnings release expected after market close on Tuesday, February 25, 2025.
Conference call at 4:30 pm ET hosted by CEO Jack Khattar and CFO Tim Dec.
Live webcast accessible on Supernus Investor Relations website; replay for 60 days.

item 2.02 item 9.01

SUPERNUS PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001356576-25-000006

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.